| Document Date: 2015-05-05 06:40:35 Open Document File Size: 287,08 KBShare Result on Facebook
City Paris / Zurich / Munich / Vienna / London / / Company Genticel / Implanet / Novartis / Atopic / Quanta / Evolva / Symetis / MPM Medical / MTM Laboratories / Omnes Capital / Sensimed / Alcon / Noemalife / Wellington Partners / Rigontec / Sapiens / Roche / pan-European Venture Capital / MDT / Supersonic Imagine / Wellington Partners Wellington Partners / Actelion / FFG / Institut Pasteur / GlaxoSmithKline Biologicals / Themis Bioscience GmbH / Xing / Wavelight / Intercell AG / Deutsche Telekom / ImmobilienScout24 / NEUWAY Pharma / Grandis / Inits / AyoxxA / Oxford Immunotec / Definiens / Themis Themis Bioscience GmbH / Spotify / GSK / / Continent Asia / Europe / Americas / / Country Austria / / Currency EUR / / / Event FDA Phase / Funding / Environmental Issue / M&A / Business Partnership / Employment Change / / Facility pipeline Vienna / / IndustryTerm biotechnology / pharmaceutical industry / increased travel activities / media enquiries / pharmaceutical / vaccine technology / digital media / / MedicalCondition Lancet Infectious Diseases / tropical infectious diseases / headache / measles / viral diseases / chronic sequela months / tropical infections / standard measles / muscle pain / fever / viral disease / Dengue / tropical diseases / acute infection / / MedicalTreatment vaccination / / Organization New Board / / Person Gerd Zettlmeissl / Robert Mayer / Jean-Paul Prieels / Regina Hodits / Themis Bioscience / Erich Tauber / / / Position General Partner / Head of Research / CEO / Chairman / Senior Vice President of R&D / Chairman of the Board / / Product Chikungunya vaccine / / Region western Africa / Caribbean / central Africa / / Technology biotechnology / vaccine technology / / URL www.themisbio.com / www.wellington-partners.com / /
SocialTag |